Get the Stockscreener App
0.236
6.65%
-0.0168
After Hours:
.23
-0.006
-2.54%
Azitra Inc stock is traded at $0.236, with a volume of 4.49M.
It is down -6.65% in the last 24 hours and up +29.67% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.2528
Open:
$0.2469
24h Volume:
4.49M
Relative Volume:
0.41
Market Cap:
$3.75M
Revenue:
$7,500
Net Income/Loss:
$-10.96M
P/E Ratio:
-0.1029
EPS:
-2.2943
Net Cash Flow:
$-11.41M
1W Performance:
+34.01%
1M Performance:
+29.67%
6M Performance:
-66.29%
1Y Performance:
-25.34%
1-Day Range:
$0.2312
$0.25
1-Week Range:
$0.2312
$0.3799
52-Week Range:
$0.10
$1.40
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.236 | 4.02M | 7,500 | -10.96M | -11.41M | -2.2943 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Azitra Inc Stock (AZTR) Latest News
Azitra Inc. (AZTR) surges over 44% after hours—here's why it's trending - MSN
Why are shares of Azitra rising? - MSN
Azitra Secures $31.4M Private Placement to Launch Innovative Protein and Peptide Programs for Cosmetic and Cosmeceutical Markets - Minichart
Azitra Secures PIPE Financing to Advance Cosmetic Programs - TipRanks
Azitra | 8-K: Current report - Moomoo
Azitra Raises $10.5M in PIPE, Up to $31.4M With Warrants; Signs Registration Rights Deal - TradingView
Azitra (NYSE: AZTR) secures up to $31.4M in PIPE with warrants - Stock Titan
AZTR Stock Price, Quote & Chart | AZITRA INC (NYSEARCA:AZTR) - ChartMill
If You Invested $1,000 in Azitra Inc (AZTR) - Stock Titan
This nano-cap pharma stock surged 80% days after a listing warning — what’s fueling the rally? - MSN
Why Are Shares Of Azitra Rising? - Sahm
Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings - Sahm
Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Sahm
Why Is AZTR Stock Rising Today? - Stocktwits
Azitra (AZTR) CEO acquires Series A preferred shares and warrants - Stock Titan
Azitra (AZTR) Stock Explodes 87% — Here’s What Triggered the Move - MEXC
Trending Stocks Today | Azitra Soars 72.28% - Moomoo
Azitra Inc stock surges 80% despite recent listing warning | Tap to know more | Inshorts - Inshorts
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Azitra raises up to $31.4m to expand into cosmetic dermatology - The Pharma Letter
Azitra (AZTR) Stock Rockets 87% Following Major Funding Announcement - MEXC
CT biotech raises up to $31.4M amid listing compliance push - Hartford Business Journal
Azitra's Emergency Funding Sparks 80% Surge—Yet Future Depends on a Risky, Highly Dilutive Bet - Bitget
Azitra CEO-backed private placement priced up to $10.5M, potential $20.9M; stock jumps 90% - MSN
Azitra (AZTR) Stock Rockets 87% Following Major Financing Announcement - parameter.io
Azitra (AZTR) Stock Rockets 87% Following Major Financing Agreement - MoneyCheck
Why Is Azitra Inc Stock (AZTR) Up Today? - TipRanks
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Azitra CEO-backed private placement priced up to $10.5M, potential $20.9M; stock jumps 90% (AZTR:NYSE) - Seeking Alpha
AZTR SEC FilingsAzitra Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Azitra Inc. (AZTR) Surges Over 44% After Hours— Here's Why It's Trending - Benzinga
Azitra secures up to $31.4M to fund cosmetic protein research By Investing.com - Investing.com Canada
Azitra, Inc. announced that it has received $10.485 million in funding from Stonepine Capital Management LLC, Nantahala Capital Management, LLC and other investors. - marketscreener.com
Azitra, Inc. (AZTR) Stock: Soars 35% After $31M Funding Boost and New Cosmetic Tech Push - parameter.io
Azitra Reports Private Placement Deal - marketscreener.com
Azitra secures up to $31.4M to fund cosmetic protein research - Investing.com
Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million - Bitget
Press Release: Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million With up to an Additional Approximately $20.9 Million - 富途牛牛
Azitra, Inc. announced that it expects to receive $10.47 million in funding from Stonepine Capital Management LLC, Nantahala Capital Management, LLC and other investors. - marketscreener.com
Azitra Crumbles Intraday: -19.5% Plunge Sparks Investor Alarm as Shorts Flood the Market - Bitget
Market Rankings: Will Azitra Inc benefit from green energy policies2026 Market Mood & Risk Controlled Stock Alerts - baoquankhu1.vn
Stock Analysis: Whats the analyst consensus on Azitra Inc2026 Buyback Activity & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Azitra Faces NYSE American Noncompliance and Delisting Risk - The Globe and Mail
Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement - Nasdaq
Azitra Receives NYSE American Non-Compliance Notice for Equity Requirement; Assesses Funding to Regain Listing Compliance - Minichart
Azitra receives NYSE delisting warning over equity shortfall By Investing.com - Investing.com Canada
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.06%
Cap:
|
Volume (24h):